about
COMP mutation screening as an aid for the clinical diagnosis and counselling of patients with a suspected diagnosis of pseudoachondroplasia or multiple epiphyseal dysplasiaPre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer.Radiation dose to heart base linked with poorer survival in lung cancer patients.Immunofluorescent localization of estrogen receptor-alpha in growth plates of rabbits, but not in rats, at sexual maturity.Acute Epithelial Toxicity Is Prognostic for Improved Prostate Cancer Response to Radiation Therapy: A Retrospective, Multicenter, Cohort StudyOutcomes of radiosensitisation in elderly patients with advanced bladder cancerPost-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapyA disorder resembling pseudoachondroplasia but without COMP mutationNovel and recurrent mutations in the C-terminal domain of COMP cluster in two distinct regions and result in a spectrum of phenotypes within the pseudoachondroplasia -- multiple epiphyseal dysplasia disease group
P50
Q36065648-1BC654B9-7FB4-4777-B2C1-ABF139EED866Q41116973-6BA4DC98-90F9-4528-A2CA-CDFC4A312648Q50131373-315A6AFA-4DD9-43FE-BBA4-AE8F082F9126Q52180244-F9C85CD1-EAEA-4C5F-94DD-936FB89E6E16Q59138792-02B71658-EAB8-4C78-B0F0-326A770659BEQ59341046-77AEB20F-0F04-41A6-B23F-C7ACFFEF596EQ62851591-D049C6B5-6942-44CA-B136-9FF1DC613645Q81025157-BAD149C4-4AF3-41FF-833C-869D537F7D9CQ81726439-ED875F52-5C6F-407A-B73B-40D71FFBEE23
P50
description
researcher ORCID ID = 0000-0002-6704-3748
@en
name
Jason Kennedy
@ast
Jason Kennedy
@en
Jason Kennedy
@es
Jason Kennedy
@nl
جايسون كينيدي
@ar
type
label
Jason Kennedy
@ast
Jason Kennedy
@en
Jason Kennedy
@es
Jason Kennedy
@nl
جايسون كينيدي
@ar
prefLabel
Jason Kennedy
@ast
Jason Kennedy
@en
Jason Kennedy
@es
Jason Kennedy
@nl
جايسون كينيدي
@ar
P1153
23497222000
57188564823
P31
P496
0000-0002-6704-3748